Fortrea Holdings FTRE
NASDAQ FTRE
$18.02 -0.60 (-3.22%)
As of: Sep 4, 2026 · 2:32 PM EDT

Fortrea Holdings (FTRE) Other Operating Expenses (2022 - 2026)

Fortrea Holdings' (FTRE) quarterly Other Operating Expenses came in at $561.3 million in Q2 2026, down 38.71% YoY from $915.8 million in Q2 2025, and up 4.06% on a QoQ basis from $539.4 million in Q1 2026.

Analysis

Fortrea Holdings (FTRE) Other Operating Expenses (2022 - 2026) Analysis & Trends

Fortrea Holdings (FTRE) has 5 years of Other Operating Expenses data on file, last reported at $561.3 million in Q2 2026.

  • Quarterly Other Operating Expenses fell 38.71% year-over-year to $561.3 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $2.3 billion (down 27.24% YoY) and the FY2025 annual result came in at $3.1 billion, up 36.65% from the prior year.
  • Other Operating Expenses climbed to $561.3 million in Q2 2026, from $539.4 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $1.0 billion in Q1 2025 to a low of $286.0 million in Q4 2022.
  • A 5-year average of $612.8 million and a median of $585.1 million in 2023 frame the typical range for Other Operating Expenses.
  • Annual changes were most pronounced in 2023 — Other Operating Expenses jumped 109.58% — and 2026, when it slumped 48.61%.
  • Tracing FTRE's Other Operating Expenses over 5 years: stood at $286.0 million in 2022, then soared by 109.58% to $599.4 million in 2023, then increased by 0.85% to $604.5 million in 2024, then slipped by 5.53% to $571.1 million in 2025, then retreated by 1.72% to $561.3 million in 2026.
  • The last three Other Operating Expenses figures came in at $561.3 million (Q2 2026), $539.4 million (Q1 2026), and $571.1 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.77 Bn 130.92 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.51 Bn 77.52 Bn 3.93 Bn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn
4 Moderna 58.20 Bn 53.06 Bn 52.00 Mn
5 Revolution Medicines 44.04 Bn 44.04 Bn -
6 BeOne Medicines 39.99 Bn 34.89 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn
8 Royalty Pharma 28.40 Bn 27.56 Bn -
9 Insmed 27.44 Bn 26.28 Bn 358.27 Mn
10 Fortrea Holdings 1.71 Bn 1.54 Bn 139.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 558.60 Mn
Mar 31, 2026 532.70 Mn
Dec 31, 2025 548.70 Mn
Sep 30, 2025 598.20 Mn
Jun 30, 2025 905.50 Mn
Mar 31, 2025 1.04 Bn
Dec 31, 2024 576.90 Mn
Sep 30, 2024 547.80 Mn
Jun 30, 2024 546.70 Mn
Mar 31, 2024 576.10 Mn
Dec 31, 2023 600.10 Mn
Sep 30, 2023 586.60 Mn
Jun 30, 2023 592.10 Mn
Mar 31, 2023 562.40 Mn
Dec 31, 2022 290.60 Mn
Sep 30, 2022 617.50 Mn
Jun 30, 2022 637.70 Mn